MCMedicalCodingSoftware
L12.31

L12.31: Epidermolysis bullosa due to drug

Billable / specific codeICD-10-CM

L12.31 is a billable, specific ICD-10-CM code for epidermolysis bullosa due to drug. It is valid for submission on a claim.

Check L12.31 with the rest of the claim: free scrubber

Use additional code

Add a secondary code to capture the detail described below.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Excludes1 inherited from the categories above L12.31

A category’s note binds every code beneath it.

Written on L12.3: Acquired epidermolysis bullosa

  • epidermolysis bullosa (congenital) (Q81.-)

Written on L12: Pemphigoid

  • herpes gestationis (O26.4-)
  • impetigo herpetiformis (L40.1)

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

L12.31 is named in 2 Medicare coverage policies: 2 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A57161Billing and Coding: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
  • A57554Billing and Coding: Immune Globulins

Alphabetic index entries that lead here

  • Epidermolysis›bullosa›acquired›drug-induced

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under L12.3

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.